Recruitment ended after the enrollment of 96 patients, of which 66 (69%) were followed for HF, 22 (23%) were followed for uncontrolled HT, 5 (5%) were followed for insulin-requiring DM, and 3 (3%) were followed for both HT and DM (Figure 2). This evidence concerns the gene INS and hydrops fetalis.